SolveBio deploys technology and on-demand expertise to drive precision medicine. We monitor, gather, and secure Genomic Intelligence.
SolveBio, founded in 2013, is a contextual knowledge hub focused on enabling pharma, biotech, and diagnostic organizations to effectively connect and use external and internal genomic information. SolveBio extracts, evaluates, and unifies complex, disparate biomedical data for life science enterprises. SolveBio is based in New York and is backed by Andreessen Horowitz, Max Levchin, Nat Turner, Elad Gil, SV Angel, Faridan Capital and other leading life sciences and technology investors. For more information, visit www.solvebio.com
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 8, 2018 | Grant | $1.49M | 1 | National Institutes of Health | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |